Vidal Total Hip Prosthesis
510(k) K770472
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK770472 | Date17 Mar 1977 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Prosthesis, Vidal Total Hip
- 510(k) Number
- FDA Product Code
- JDL
- Device Class
- Class III
- Regulation
- 21 CFR Part 888.3320
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Vidal Total Hip Prosthesis is a semi-constrained, metal cemented acetabular component designed for total hip joint replacement. It is classified as a Class III medical device under FDA regulations, intended for use in orthopedic surgical procedures to restore hip function in patients with degenerative joint disease, fractures, or other conditions requiring arthroplasty.
This device is supplied as a reusable surgical implant and is intended for use in sterile operating environments. It is regulated under FDA 510(k) clearance (K770472) and falls under product code JDL. The prosthesis requires proper surgical technique for implantation, including cement fixation to the acetabulum, and is not intended for MRI use. Storage and handling must comply with sterile medical device protocols.
Other devices from Howmedica Corp.
Questions
AI-generated answers, 18 Sep 2026
What types of patients is the Vidal Total Hip Prosthesis designed for, and what conditions does it address?
The Vidal Total Hip Prosthesis is designed for patients requiring total hip joint replacement due to degenerative joint disease, fractures, or other conditions necessitating arthroplasty. It is a semi-constrained, metal cemented acetabular component intended to restore hip function in these cases. The device is not intended for use in patients who require MRI imaging, as it is not MRI-compatible.
How is the Vidal Total Hip Prosthesis supplied, and what are the key considerations for its use in surgery?
The Vidal Total Hip Prosthesis is supplied as a reusable surgical implant, meaning it is intended for single-use per patient and must be discarded after implantation. It requires sterile handling and use in sterile operating environments. Proper surgical technique is essential, including cement fixation to the acetabulum, to ensure correct placement and function.
What regulatory pathway was followed for the FDA clearance of the Vidal Total Hip Prosthesis, and what does this mean for its use?
The Vidal Total Hip Prosthesis received FDA clearance through a 510(k) submission (K770472), classified under product code JDL and reviewed by the Orthopedic (OR) Advisory Committee. The device was determined to be substantially equivalent to a legally marketed predicate, meaning it meets FDA standards for safety and effectiveness as a Class III medical device. This clearance does not imply any specific clinical indication beyond what is stated in the device description.
Are there multiple sizes or models available for the Vidal Total Hip Prosthesis, and how are they identified?
Yes, the Vidal Total Hip Prosthesis comes in multiple sizes and models, as indicated by the extensive list of FEI numbers (e.g., 3020282716, 3007923096) and registration numbers (e.g., 8043792, 2242737) in the data. These identifiers correspond to distinct acetabular component sizes or variations, which must be selected based on the patient’s anatomy and surgical requirements. The exact sizing details would typically be provided in the manufacturer’s surgical technique guide.
What storage and handling precautions must be followed for the Vidal Total Hip Prosthesis to maintain sterility?
Since the Vidal Total Hip Prosthesis is intended for use in sterile operating environments, it must be stored and handled according to standard sterile medical device protocols. This includes proper packaging, protection from contamination, and adherence to manufacturer guidelines for shelf life and expiration. The device should not be reused after implantation, as it is designed for single-use per patient.